Tuberculosis, Multidrug-Resistant

Displaying 1 - 5 of 5CSV
Brown, T. S., Tang, L., Omar, S. V., Joseph, L., Meintjes, G., Maartens, G., Wasserman, S., Shah, N. S., Farhat, M. R., Gandhi, N. R., Ismail, N., Brust, J. C. M., & Mathema, B. (2023). Genotype–Phenotype Characterization of Serial Mycobacterium tuberculosis Isolates in Bedaquiline-Resistant Tuberculosis. Clinical Infectious Diseases, 78(2), 269–276. https://doi.org/10.1093/cid/ciad596
Publication Date
Ross, J., Perumal, R., Wolf, A., Zulu, M., Guzman, K., Seepamore, B., Reis, K., Nyilana, H., Hlathi, S., Narasimmulu, R., Cheung, Y. K. K., Amico, K. R., Friedland, G., Daftary, A., Zelnick, J. R., Naidoo, K., & O’Donnell, M. R. (2023). Adaptive evaluation of mHealth and conventional adherence support interventions to optimize outcomes with new treatment regimens for drug-resistant tuberculosis and HIV in South Africa (ADAP-TIV): study protocol for an adaptive randomized controlled trial. Trials, 24(1). https://doi.org/10.1186/s13063-023-07520-9
Publication Date
Wang, L., Chen, B., Zhou, H., Mathema, B., Chen, L., Li, X., Lu, Y., Liu, Z., Wang, X., & Wang, W. (2023). Emergence and evolution of drug-resistant Mycobacterium tuberculosis in eastern China: A six-year prospective study. Genomics, 115(3), 110640. https://doi.org/10.1016/j.ygeno.2023.110640
Publication Date
Bateman, M., Wolf, A., Chimukangara, B., Brust, J. C. M., Lessells, R., Amico, R., Boodhram, R., Singh, N., Orrell, C., Friedland, G., Naidoo, K., Padayatchi, N., & O’Donnell, M. R. (2022). Adherence Measured Using Electronic Dose Monitoring is Associated with Emergent Antiretroviral Resistance and Poor Outcomes in People with Human Immunodeficiency Virus/AIDS and Multidrug-Resistant Tuberculosis. Clinical Infectious Diseases, 75(9), 1489–1496. https://doi.org/10.1093/cid/ciac232
Publication Date
O’Donnell, M. R., Padayatchi, N., Wolf, A., Zelnick, J., Daftary, A., Orrell, C., Nimmo, C., Baldwin, M., Boodhram, R., Maharaj, B., Amico, K. R., Naidoo, K., & Friedland, G. (2022). Bedaquiline Adherence Measured by Electronic Dose Monitoring Predicts Clinical Outcomes in the Treatment of Patients With Multidrug-Resistant Tuberculosis and HIV/AIDS. JAIDS Journal of Acquired Immune Deficiency Syndromes, 90(3), 325–332. https://doi.org/10.1097/qai.0000000000002940
Publication Date